Literature DB >> 12784270

Sleepiness in Parkinson's disease: a controlled study.

Matthew A Brodsky1, James Godbold, Tom Roth, C Warren Olanow.   

Abstract

Sudden-onset sleep episodes while driving have been reported in Parkinson's disease (PD) patients, and termed sleep attacks because they were reported to be irresistible and to occur without warning. We postulate that these episodes are due to excessive daytime sleepiness secondary to the high frequency of sleep disorders in PD patients and the sedative effects of dopaminergic medications. We assessed the frequency and relationship between excess daytime sleepiness and sleep episodes while driving (SE) in patients with PD. We evaluated 101 consecutive PD patients presenting to the Movement Disorder Center at the Mount Sinai School of Medicine using a questionnaire that incorporated a subjective estimate of sleepiness, the Epworth Sleepiness Scale (ESS) and information on disease severity and dopaminergic medications. One hundred age-matched respondents without PD served as a control population. Excess daytime sleepiness was reported in 76% of PD patients compared to 47% of controls (P < 0.05). The mean ESS scores for PD patients was 9.1 +/- 6.1 versus 5.7 +/- 4.4 in controls (P < 0.001). ESS scores > or =10 were observed in 40.6% of PD patients compared to 19% of controls (P < 0.01) and 24% of PD patients had scores > or =15, compared to 5% of controls (P < 0.001). Sleep episodes while driving were experienced by 20.8% of PD drivers compared to 6% of control drivers (P < 0.05). The mean daily levodopa (L-dopa) dose equivalent was 1,142 +/- 858 mg in PD drivers who experienced a SE while driving compared to 626 +/- 667 mg in those who had not (P < 0.05). Similarly, ESS was significantly greater in drivers with a SE than in those without (11.6 +/- 6.4 vs. 8.4 +/- 4.1; P < 0.05). Logistic regression analysis demonstrated that ESS and mean daily L-dopa dose equivalents were predictors of sleep episodes while driving, whereas age, gender, disease severity, and individual dopaminergic agents were not. These findings support the notion that sleep episodes while driving in PD patients are related to excess daytime sleepiness and dopaminergic load. Physicians should advise and treat patients accordingly. Copyright 2003 Movement Disorder Society

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12784270     DOI: 10.1002/mds.10429

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  32 in total

Review 1.  A systematic review of patient-reported outcome instruments measuring sleep dysfunction in adults.

Authors:  Emily Beth Devine; Zafar Hakim; Jesse Green
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

2.  Parkinsonism with excessive daytime sleepiness--a narcolepsy-like disorder?

Authors:  Christian Baumann; Luigi Ferini-Strambi; Daniel Waldvogel; Esther Werth; Claudio Lino Bassetti
Journal:  J Neurol       Date:  2005-02       Impact factor: 4.849

Review 3.  Circadian and sleep disorders in Parkinson's disease.

Authors:  Aleksandar Videnovic; Diego Golombek
Journal:  Exp Neurol       Date:  2012-08-23       Impact factor: 5.330

Review 4.  Excessive daytime sleepiness and unintended sleep episodes associated with Parkinson's disease.

Authors:  Fatai Salawu; Abdulfatai Olokoba
Journal:  Oman Med J       Date:  2015-01

Review 5.  Clinical review and treatment of select adverse effects of dopamine receptor agonists in Parkinson's disease.

Authors:  Lindy D Wood
Journal:  Drugs Aging       Date:  2010-04-01       Impact factor: 3.923

6.  Excessive daytime sleepiness and topographic expansion of Lewy pathology.

Authors:  Robert D Abbott; G Webster Ross; John E Duda; Chol Shin; Jane H Uyehara-Lock; Kamal H Masaki; Lenore J Launer; Lon R White; Caroline M Tanner; Helen Petrovitch
Journal:  Neurology       Date:  2019-08-30       Impact factor: 9.910

7.  Widespread cortical and subcortical brain atrophy in Parkinson's disease with excessive daytime sleepiness.

Authors:  S Kato; H Watanabe; J Senda; M Hirayama; M Ito; N Atsuta; T Kaga; M Katsuno; S Naganawa; G Sobue
Journal:  J Neurol       Date:  2011-08-18       Impact factor: 4.849

8.  Sleep disorders in Parkinson's disease.

Authors:  Cynthia L Comella
Journal:  Curr Treat Options Neurol       Date:  2008-05       Impact factor: 3.598

Review 9.  Beyond tremor and rigidity: non-motor features of Parkinson's disease.

Authors:  Matthias Löhle; Alexander Storch; Heinz Reichmann
Journal:  J Neural Transm (Vienna)       Date:  2009-08-14       Impact factor: 3.575

10.  Sleep disorders in Parkinson's disease.

Authors:  Israt Jahan; Robert A Hauser; Kelly L Sullivan; Amber Miller; Theresa A Zesiewicz
Journal:  Neuropsychiatr Dis Treat       Date:  2009-11-02       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.